Facultade de Medicina e Odontoloxía
Facultad
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaPublicacións en colaboración con investigadores/as de Ikerbasque, Fundación Vasca para la Ciencia (14)
2024
-
Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors
Journal of Controlled Release, Vol. 373, pp. 277-292
-
Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke
iScience, Vol. 27, Núm. 11
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
A tetracationic porphyrin with dual anti-prion activity
iScience, Vol. 26, Núm. 9
-
Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders
Biomedicines, Vol. 11, Núm. 2
-
Understanding the key features of the spontaneous formation of bona fide prions through a novel methodology that enables their swift and consistent generation
Acta Neuropathologica Communications, Vol. 11, Núm. 1
2022
-
Bona fide atypical scrapie faithfully reproduced for the first time in a rodent model
Acta Neuropathologica Communications, Vol. 10, Núm. 1
2021
-
O-GlcNAcylated p53 in the liver modulates hepatic glucose production
Nature Communications, Vol. 12, Núm. 1
2019
2018
-
Cofactors influence the biological properties of infectious recombinant prions
Acta Neuropathologica, Vol. 135, Núm. 2, pp. 179-199
2017
-
An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein
PLoS ONE, Vol. 12, Núm. 8
-
Generation of a new infectious recombinant prion: A model to understand Gerstmann-Sträussler-Scheinker syndrome
Scientific Reports, Vol. 7, Núm. 1
-
Hepatic p63 regulates steatosis via IKKβ/ER stress
Nature Communications, Vol. 8